Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
205.00    5.10 (2.55%)
Bid:
205.60
Ask:
207.20
Spread: 1.60 (0.778%)
Market Cap: £1.71b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Statement regarding AutoStore

11 Mar 2022 08:01

RNS Number : 4880E
Ocado Group PLC
11 March 2022
 

OCADO GROUP PLC

11 March 2022

 

Ocado Group plc

ITC investigation over: conclusive victory for Ocado

ITC confirms all AutoStore cavity bot patents are invalid

On 10th March, the International Trade Commission, consisting of 5 experienced patent judges, decided in favour of Ocado on all points. Every patent AutoStore asserted in its ITC complaint was found either invalid or not infringed by Ocado's proprietary state of the art technology.

All of the 33 claims that originally constituted AutoStore's complaint to the ITC have now been rejected for a second time, or abandoned by AutoStore. AutoStore's key cavity bot patents, the UK versions of which are the only patents being asserted against Ocado in the High Court case starting next week, were all found to be invalid. A fourth, unrelated, patent was held not to be infringed.

Unusually, the ITC accepted review of the judge's original decision and in the same notice gave its decision on the merits, which further emphasises the strength of these findings.

Ocado continues actively to pursue its claims against AutoStore for infringement of Ocado's IP rights in both the United States and Europe, including its antitrust "Walker Process" claim against AutoStore in East Virginia and its infringement of five Ocado patents in New Hampshire. Ocado anticipates court determinations injuncting AutoStore and awarding Ocado damages for AutoStore's infringement of Ocado's patents.

An Ocado spokesperson said:

"We welcome the ITC's decision, which comprehensively confirms the judge's original findings last December. All 33 of the patent claims asserted against Ocado have now been confirmed for a second time to be either invalid or not infringed, demonstrating again how misguided AutoStore's complaint has been. The ITC investigation is now at its end.

 

We expect further vindication in the High Court in London in the weeks ahead, where AutoStore has already abandoned half of the patents in the case."

 

Contacts

● David Shriver, Director of Communications, Ocado Group plc, on 01707 228 000

● Martin Robinson at Tulchan Communications on 020 7353 4200

 

 

 

Person responsible for arranging the release of this announcement:

 

Neill Abrams

Group General Counsel & Company Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

Fax: +44 (0)1707 227 997

email: company.secretary@ocado.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFIFEDVAILLIF
Date   Source Headline
28th Sep 20185:06 pmRNSTotal Voting Rights
21st Sep 20186:01 pmRNSDirector/PDMR Shareholding
21st Sep 20182:17 pmRNSDirector/PDMR Shareholding
20th Sep 20185:29 pmRNSDirector/PDMR Shareholding
20th Sep 20185:25 pmRNSDirector/PDMR Shareholding
19th Sep 20189:43 amRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSTrading Statement
13th Sep 20181:21 pmRNSChange of Director's Details
7th Sep 20184:52 pmRNSHolding(s) in Company
31st Aug 20185:59 pmRNSDirector/PDMR Shareholding
31st Aug 20185:46 pmRNSTotal Voting Rights
31st Aug 20189:32 amRNSHolding(s) in Company
28th Aug 20183:16 pmRNSDirector/PDMR Shareholding
17th Aug 20184:46 pmRNSDirector/PDMR Shareholding
15th Aug 20182:45 pmRNSDirector/PDMR Shareholding
31st Jul 20185:47 pmRNSTotal Voting Rights
26th Jul 201812:09 pmRNSBlock listing Interim Review
20th Jul 20184:18 pmRNSHolding(s) in Company
17th Jul 20184:39 pmRNSDirector/PDMR Shareholding
16th Jul 20182:16 pmRNSDirector/PDMR Shareholding
13th Jul 20184:48 pmRNSDirector/PDMR Shareholding
13th Jul 20182:19 pmRNSDirector/PDMR Shareholding
10th Jul 20187:00 amRNSHalf-year Report
5th Jul 20187:00 amRNSDirectorate Change
29th Jun 20185:03 pmRNSTotal Voting Rights
4th Jun 20185:59 pmRNSDirector/PDMR Shareholding
4th Jun 20185:58 pmRNSDirector/PDMR Shareholding
4th Jun 20185:57 pmRNSDirector/PDMR Shareholding
4th Jun 20185:57 pmRNSDirector/PDMR Shareholding
4th Jun 20183:12 pmRNSHolding(s) in Company
1st Jun 20185:38 pmRNSHolding(s) in Company
1st Jun 20189:48 amRNSTotal Voting Rights
1st Jun 20187:00 amRNSHolding(s) in Company
30th May 20187:00 amRNSHolding(s) in Company
30th May 20187:00 amRNSHolding(s) in Company
24th May 20184:00 pmRNSApplication for Listing and Total Voting Rights
21st May 20183:20 pmRNSHolding(s) in Company
17th May 20187:00 amRNSStatement regarding new international partnership
15th May 20184:24 pmRNSDirector/PDMR Shareholding
4th May 20186:01 pmRNSHolding(s) in Company
3rd May 201811:30 amRNSHolding(s) in Company
2nd May 20183:29 pmRNSResult of AGM
2nd May 20187:00 amRNSStatement regarding new international partnership
30th Apr 20185:14 pmRNSTotal Voting Rights
26th Apr 201810:10 amRNSHolding(s) in Company
20th Apr 20184:24 pmRNSHolding(s) in Company
19th Apr 20185:07 pmRNSDirector/PDMR Shareholding
12th Apr 20185:32 pmRNSCommittee Chairman Appointment
11th Apr 20184:59 pmRNSDirector/PDMR Shareholding
11th Apr 20184:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.